Ixekizumab

Common brands: Taltz, Cosentyx, Humira, Methotrexate, Otrexup

Top reporter: Eli Lilly And Company

Interleukin-17A Antagonist [EPC]Tumor Necrosis Factor Blocker [EPC]Folate Analog Metabolic Inhibitor [EPC]Interleukin-23 Antagonist [EPC]Corticosteroid [EPC]
36,303
Total Reports
19,206
Serious Reports
539
Death Reports
30
Reported Reactions
Death Report Ratio: Moderate (1.48%)

Patient Demographics

Male
12,895
Female
20,151

Reported Adverse Reactions (30)

Side effects reported in FDA adverse event reports for Ixekizumab.

# Reaction Reports % of Total
1 INJECTION SITE PAIN 3,866
11.6%
2 DRUG INEFFECTIVE 3,217
9.7%
3 PSORIASIS 3,205
9.6%
4 INJECTION SITE ERYTHEMA 2,178
6.5%
5 INJECTION SITE REACTION 1,773
5.3%
6 INJECTION SITE SWELLING 1,637
4.9%
7 INCORRECT DOSE ADMINISTERED 1,165
3.5%
8 PRODUCT DOSE OMISSION ISSUE 940
2.8%
9 COVID-19 920
2.8%
10 PAIN 891
2.7%
11 ARTHRALGIA 874
2.6%
12 THERAPY INTERRUPTED 826
2.5%
13 DIARRHOEA 817
2.5%
14 RASH 814
2.4%
15 INJECTION SITE PRURITUS 788
2.4%
16 PRURITUS 787
2.4%
17 PSORIATIC ARTHROPATHY 766
2.3%
18 NAUSEA 755
2.3%
19 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 673
2.0%
20 INJECTION SITE URTICARIA 665
2.0%
21 FATIGUE 655
2.0%
22 NASOPHARYNGITIS 643
1.9%
23 INJECTION SITE MASS 609
1.8%
24 OFF LABEL USE 603
1.8%
25 INJECTION SITE HAEMORRHAGE 600
1.8%
26 HEADACHE 570
1.7%
27 INJECTION SITE RASH 537
1.6%
28 MALAISE 531
1.6%
29 URTICARIA 525
1.6%
30 INFECTION 506
1.5%

Important Disclaimer

FDA adverse event reports are submitted voluntarily and do not prove causation. A reported reaction does not mean the drug caused it. Drugs with more users naturally have more reports. Always consult your doctor or pharmacist before making medication decisions.